NextCure, Inc. (NASDAQ:NXTC) showed up in the 13F filings of 24 institutional investors as of March 2026.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Squadron Capital Management LLC | 31 Mar, 2026 | 265,000 | 28,034 | 11.83% | $2,830,200.00 |
| Affinity Asset Advisors, LLC | 31 Mar, 2026 | 241,826 | -5,468 | -2.21% | $2,582,702.00 |
| Ikarian Capital, LLC | 31 Mar, 2026 | 238,303 | 0 | 0.00% | $2,506,947.00 |
| Sofinnova Investments, Inc. | 31 Mar, 2026 | 222,654 | 0 | 0.00% | $2,377,945.00 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 176,057 | 0 | 0.00% | $1,880,289.00 |
| Pfizer Inc | 31 Mar, 2026 | 153,354 | -4,292 | -2.72% | $1,535,074.00 |
| Opaleye Management Inc. | 31 Mar, 2026 | 141,181 | 141,181 | 0.00% | $1,507,813.00 |
| AWM Investment Company, Inc. | 31 Mar, 2026 | 117,371 | 0 | 0.00% | $1,234,743.00 |
| Exome Asset Management LLC | 31 Mar, 2026 | 115,500 | -49,500 | -30.00% | $1,215,060.00 |
| BOOTHBAY FUND MANAGEMENT, LLC | 31 Mar, 2026 | 69,617 | 0 | 0.00% | $743,510.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Mar, 2026 | 60,534 | 26,900 | 79.98% | $646,503.00 |
| Verdad Advisers, LP | 31 Mar, 2026 | 42,955 | 42,955 | 0.00% | $458,759.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 31,092 | 7,935 | 34.27% | $327,136.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 27,793 | 0 | 0.00% | $296,830.00 |
| Woodline Partners LP | 31 Mar, 2026 | 27,498 | 27,498 | 0.00% | $293,679.00 |
| CARDIFF PARK ADVISORS, LLC | 31 Mar, 2026 | 21,833 | 0 | 0.00% | $233,176.00 |
| ACADIAN ASSET MANAGEMENT LLC | 31 Mar, 2026 | 18,982 | -7,783 | -29.08% | $199.00 |
| CITADEL ADVISORS LLC | 31 Mar, 2026 | 15,292 | 15,292 | 0.00% | $160,872.00 |
| Barclays Plc | 31 Mar, 2026 | 5,626 | 0 | 0.00% | $60,085.00 |
| UBS Group AG | 31 Mar, 2026 | 338 | 0 | 0.00% | $3,610.00 |